P3a amplitude to trauma-related stimuli reduced after successful trauma-focused PTSD treatment.

Autor: Tillman GD; Callier Center, University of Texas at Dallas, Dallas, TX, USA. Electronic address: gtillman@utdallas.edu., Morris EE; Callier Center, University of Texas at Dallas, Dallas, TX, USA., Bass C; Callier Center, University of Texas at Dallas, Dallas, TX, USA., Turner M; Departments of Psychiatry University of Texas Southwestern Medical Center, Dallas, TX, USA., Watson K; Callier Center, University of Texas at Dallas, Dallas, TX, USA., Brooks JT; Callier Center, University of Texas at Dallas, Dallas, TX, USA., Rawlinson T; Callier Center, University of Texas at Dallas, Dallas, TX, USA., Kozel FA; Department of Behavioral Sciences and Social Medicine, Florida State University, Tallahassee, FL, USA., Kraut MA; Department of Radiology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA., Motes MA; Callier Center, University of Texas at Dallas, Dallas, TX, USA., Hart J Jr; Callier Center, University of Texas at Dallas, Dallas, TX, USA; Departments of Psychiatry University of Texas Southwestern Medical Center, Dallas, TX, USA; Departments of Neurology, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Publikováno v: Biological psychology [Biol Psychol] 2023 Sep; Vol. 182, pp. 108648. Date of Electronic Publication: 2023 Jul 22.

Efficacy of the novel Plasmodium falciparum blood-stage vaccine RH5.1/AS01B in a phase I/IIA clinical trial

Autor: Minassian, A, Silk, S, Poulton, I, Mitton, C, Payne, R, Rawlinson, T, Barrett, J, Baker, M, Ramon, R, Lopez, F, Edwards, N, Ellis, K, Nielsen, C, Quinkert, D, Barfod, L, Miura, K, Diouf, A, Folegatti, P, Silman, D, Datoo, M, Smith, R, Berrie, E, Morelle, D, Lievens, M, Noe, A, Diggs, C, Soisson, L, Ashfield, R, Long, C, Nugent, F, Lawrie, A, Draper, S

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1064::96c5fea7a0e83b87ecfc3085b7c1ec88
https://doi.org/10.4269/ajtmh.abstract2018

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.

Autor: Ramasamy MN; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK. Electronic address: maheshi.ramasamy@paediatrics.ox.ac.uk., Minassian AM; The Jenner Institute, University of Oxford, Oxford, UK., Ewer KJ; The Jenner Institute, University of Oxford, Oxford, UK., Flaxman AL; The Jenner Institute, University of Oxford, Oxford, UK., Folegatti PM; The Jenner Institute, University of Oxford, Oxford, UK., Owens DR; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK., Voysey M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Aley PK; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Angus B; The Jenner Institute, University of Oxford, Oxford, UK., Babbage G; The Jenner Institute, University of Oxford, Oxford, UK., Belij-Rammerstorfer S; The Jenner Institute, University of Oxford, Oxford, UK., Berry L; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK., Bibi S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Bittaye M; The Jenner Institute, University of Oxford, Oxford, UK., Cathie K; Paediatric Medicine, University of Southampton, Southampton, UK., Chappell H; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK., Charlton S; National Infection Service, Public Health England, Porton Down, Salisbury, UK., Cicconi P; The Jenner Institute, University of Oxford, Oxford, UK., Clutterbuck EA; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK., Colin-Jones R; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Dold C; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK., Emary KRW; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Fedosyuk S; The Jenner Institute, University of Oxford, Oxford, UK., Fuskova M; The Jenner Institute, University of Oxford, Oxford, UK., Gbesemete D; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK., Green C; Clinical Biomanufacturing Facility, University of Oxford, Oxford, UK., Hallis B; National Infection Service, Public Health England, Porton Down, Salisbury, UK., Hou MM; The Jenner Institute, University of Oxford, Oxford, UK., Jenkin D; The Jenner Institute, University of Oxford, Oxford, UK., Joe CCD; The Jenner Institute, University of Oxford, Oxford, UK., Kelly EJ; AstraZeneca BioPharmaceuticals Research and Development, Washington, DC, USA., Kerridge S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Lawrie AM; The Jenner Institute, University of Oxford, Oxford, UK., Lelliott A; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Lwin MN; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK., Makinson R; The Jenner Institute, University of Oxford, Oxford, UK., Marchevsky NG; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Mujadidi Y; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Munro APS; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK., Pacurar M; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK., Plested E; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Rand J; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK., Rawlinson T; The Jenner Institute, University of Oxford, Oxford, UK., Rhead S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK., Robinson H; Nuffield Department of Medicine, and Oxford Centre for Clinical Tropical Medicine and Global Health, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK., Ritchie AJ; The Jenner Institute, University of Oxford, Oxford, UK., Ross-Russell AL; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK., Saich S; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK., Singh N; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Smith CC; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Snape MD; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Song R; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA., Tarrant R; Clinical Biomanufacturing Facility, University of Oxford, Oxford, UK., Themistocleous Y; The Jenner Institute, University of Oxford, Oxford, UK., Thomas KM; National Infection Service, Public Health England, Porton Down, Salisbury, UK., Villafana TL; AstraZeneca BioPharmaceuticals Research and Development, Bethesda, MA, USA., Warren SC; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK., Watson MEE; The Jenner Institute, University of Oxford, Oxford, UK., Douglas AD; The Jenner Institute, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK., Hill AVS; The Jenner Institute, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK., Lambe T; The Jenner Institute, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK., Gilbert SC; The Jenner Institute, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK., Faust SN; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Trust and Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK., Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.

Publikováno v: Lancet (London, England) [Lancet] 2021 Dec 19; Vol. 396 (10267), pp. 1979-1993. Date of Electronic Publication: 2020 Nov 19.

In Silico Design of a Trans‐Amplifying RNA‐Based Vaccine against SARS‐CoV‐2 Structural Proteins.

Autor: Nafian, Fatemeh¹ (AUTHOR) f.nafian@iautmu.ac.ir, Soleymani, Ghazal² (AUTHOR), Pourmanouchehri, Zahra³ (AUTHOR), Kiyanjam, Mahnaz⁴ (AUTHOR), Nafian, Simin⁵ (AUTHOR), Mohammadi, Sayed Mohammad⁶ (AUTHOR), Jeyroudi, Hanie⁴ (AUTHOR), Berenji Jalaei, Sharareh⁷ (AUTHOR), Sabzpoushan, Fatemeh⁴ (AUTHOR), Zannella, Carla (AUTHOR)

Publikováno v: Advances in Virology. 9/29/2024, Vol. 2024, p1-21. 21p.

COVID-19 Vaccines in the Pediatric Population: A Focus on Cardiac Patients.

Autor: Lababidi, Ghena¹ (AUTHOR), Lababidi, Hossam¹ (AUTHOR), Bitar, Fadi² (AUTHOR), Arabi, Mariam² (AUTHOR)

Publikováno v: Canadian Journal of Infectious Diseases & Medical Microbiology. 5/15/2024, Vol. 2024, p1-12. 12p.